Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Calif. Safe Cosmetics Act

This article was originally published in The Rose Sheet

Executive Summary

California Department of Health Services' budget for Senate Bill 484 may be finalized this summer, "possibly by July," according to Linda Loretz, PhD, director for safety and regulatory toxicology for the Cosmetic, Toiletry and Fragrance Association. She presented during the Strategic Research Institute-sponsored Cosmeceuticals meeting in New York City June 8-9. Loretz noted several new positions have been filled to enforce the act, but it is unclear how many of those positions will make it past the budgeting process. Effective Jan. 1, 2007, SB 484 requires manufacturers of cosmetics subject to FDA regulation and sold in California to report to the DHS use of any chemical known to the state as causing cancer or reproductive toxicity (1"The Rose Sheet" Oct. 17, 2005, p. 3)...
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

RS014006

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel